Taiwan FDA registration 8a31527ed05929e27178ff0005b78d0a
Insulin growth hormone IGBP-3
TW: 常盈胰島素生長激素IGBP-3
Taiwan·Risk Class 2·DIAGNOSTIC SYSTEMS LABORATORIES, INC.·Registered Mar 22, 2006 – Mar 22, 2011CancelledRegistration details
- Analysis ID
- 8a31527ed05929e27178ff0005b78d0a
- Customs Code
- DHA00601619804
Company information
- Manufacturer
- DIAGNOSTIC SYSTEMS LABORATORIES, INC.
- Manufacturer Country
- United States
- Authorized Representative
- WOLCH ENTERPRISES INC.
Product details
- Intended Use
- Quantitative determination of IGFBP-3 in serum.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1370 Human Growth Hormone Testing System
- Import Information
- import
Dates and status
- Registration Date
- Mar 22, 2006
- Expiry Date
- Mar 22, 2011
- Cancellation Date
- Nov 26, 2012
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Insulin growth hormone IGBP-3 in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 8a31527ed05929e27178ff0005b78d0a and manufactured by DIAGNOSTIC SYSTEMS LABORATORIES, INC.. The authorized representative in Taiwan is WOLCH ENTERPRISES INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices